Howard Osterman, DPM
Podiatrist · Silver Spring, MDNPI 1275505471
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,252 with a category attached, or 73.8%. Supreme Orthopedic Systems, LLC accounts for 74.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $1,244 and has fallen 90.4% since, to $120 in 2025.
Across 21 payments — averaging $154.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$2K
- Kerecis Limited$214
- Organogenesis Inc.$134
- Biopro, Inc.$105
- Amgen$103
- Orthofix Medical, Inc.$89
- plus $192 from 9 others
What the payments were for
- Speaking & faculty fees$1154%
- Food & beverage$73723%
- Education$2,40074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 3 | $2,415 |
| Kerecis Limited | 2 | $214 |
| Organogenesis Inc. | 2 | $134 |
| Biopro, Inc. | 1 | $105 |
| Amgen | 1 | $103 |
| Orthofix Medical, Inc. | 1 | $89 |
| Medtronic | 2 | $35 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Nevro Corp. | 1 | $28 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Mimedx Group, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,252 in reported general payments places this provider in the 80th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 27 | $645 |
| Ketoconazole | 15 | $455 |
| Meloxicam | 121 | $440 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Silver Spring
- Holly BeckSilver Spring$15K
- Brandon BlankenSilver Spring$12K
- Haseeb AhmadSilver Spring$9K
- Priya ParthasarathySilver Spring$6K
- Steven BlankenSilver Spring$5K
- Jennifer GerresSilver Spring$3K
- Adam LowySilver Spring$3K
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.